Concepedia

David A. Griffith

DA

54

Publications

3.5K

Citations

27

H-Index

1979

Active since

Affiliations

Pfizer (United States)(Current)

The University of Queensland

University of California, Berkeley

David A. Griffith is an author at Pfizer (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

MedicinePharmacologyBiochemistryNatural SciencesDrug DiscoveryOrganic ChemistryPharmacotherapyMedicinal ChemistryEngineeringChemistry

Publications per year

1979–2022

54

Publications

54

SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1

Michelle Pacholec, John E. Bleasdale, Boris A. Chrunyk et al. · Journal of Biological Chemistry · 2010 · 889 citations · Full text

Molecular Biology, Compounds Srt2183, Molecular Research +16

Sulfonamidoglycosylation of glycals. A route to oligosaccharides with 2-aminohexose subunits

David A. Griffith, Samuel J. Danishefsky · Journal of the American Chemical Society · 1990 · 219 citations

Biosynthesis, Bioorganic Chemistry, Engineering +11

Total synthesis of allosamidin: an application of the sulfonamidoglycosylation of glycals

David A. Griffith, Samuel J. Danishefsky · Journal of the American Chemical Society · 1991 · 159 citations

Bioorganic Chemistry, Chemical Analysis, Glycobiology +18

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

David A. Griffith, David J. Edmonds, Jean‐Philippe Fortin et al. · Journal of Medicinal Chemistry · 2022 · 140 citations · Full text

Insulin Signaling, Gastrointestinal Peptide Hormone, Molecular Pharmacology +17

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

Daniel S. Nielsen, Huy N. Hoang, Rink‐Jan Lohman et al. · Angewandte Chemie International Edition · 2014 · 138 citations

Rows per page

1–5 of 54